Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:32953265

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma.

Chaozhi Tang · Jiakang Ma · Xiuli Liu · Zhengchun Liu

PeerJ · 2020 doi:10.7717/peerj.9774

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:32953265
kind
science-record
content_hash
sha256:50270002525b5e4851090551c10081f269e5a2e5f6e12e26f9a77c90423a46c6
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:10Z
updated_at
2026-11-01T22:02:13Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma.
doi
10.7717/peerj.9774
pmid
32953265
authors array · 4 items
[0]
Chaozhi Tang
[1]
Jiakang Ma
[2]
Xiuli Liu
[3]
Zhengchun Liu
journal
PeerJ
year
2020
abstract
BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common cancer. Since changes in liver metabolism contribute to liver disease development, it is necessary to build a metabolism-related prognostic model for HCC. METHODS: We constructed a metabolism-related-gene (MRG) signature comprising nine genes, which segregated HCC patients into high- and low-risk groups. RESULTS: The survival rate (overall survival: OS; relapse-free survival; and progression-free survival) of patients in the low-risk group of The Cancer Genome Atlas (TCGA) cohort was significantly higher than that of patients in the high-risk group. The OS prognostic signature was validated in the International Cancer Genome Consortium independent cohort. The corresponding receiver operating characteristic curves of the model indicated that the signature had good diagnostic efficiency, in terms of improving OS over 1, 3, and 5 years. Hierarchical analysis demonstrated that the MRG signature was significantly associated with better prognosis in male patients, patients aged ≤ 65 years, and patients carrying the wild-type TP53 or CTNNB1 genes. A nomogram was established, and good performance and clinical practicability were confirmed. Additionally, using the GSE109211 dataset from the Gene Expression Omnibus database, we were able to verify that the nine genes in this MRG signature had different responses to sorafenib, suggesting that some of these MRGs may act as therapeutic targets for HCC. CONCLUSIONS: We believe that these findings will add value in terms of the diagnosis, treatment, and prognosis of HCC.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
Next, the “glmnet” package was used to implement the LASSO Cox regression model. For the discovery cohort (n = 374 patients), fragments per kilobase of exon per million mapped reads (FPKM) data and the corresponding clinical information related to gene expression were downloaded from The Cancer Genome Atlas (TCGA). For the validation cohort (n = 243 patients), the original data and corresponding clinical data related to gene expression were downloaded from the Liver Cancer-RIKEN, Japan (LIRI-JP) project of the International Cancer Genome Consortium (ICGC).
kind
methodological
target
null
evidence array · 3 items
[0] object · 3 fields
asset
source:pmid:32953265
locator
sections[4] "Identification of a prognostic signature based on differential MRG expression" paragraph 2
quote
Next, the “glmnet” package was used to implement the LASSO Cox regression model.
[1] object · 3 fields
asset
source:pmid:32953265
locator
sections[3] "Data processing and extraction of differentially expressed MRGs" paragraph 2
quote
For the discovery cohort (n = 374 patients), fragments per kilobase of exon per million mapped reads (FPKM) data and the corresponding clinical information related to gene expression were downloaded from The Cancer Genome Atlas (TCGA).
[2] object · 3 fields
asset
source:pmid:32953265
locator
sections[3] "Data processing and extraction of differentially expressed MRGs" paragraph 2
quote
For the validation cohort (n = 243 patients), the original data and corresponding clinical data related to gene expression were downloaded from the Liver Cancer-RIKEN, Japan (LIRI-JP) project of the International Cancer Genome Consortium (ICGC).
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The following information was supplied regarding data availability: The data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov). under TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32953265
locator
sections[31] "Data Availability Statement" paragraphs 1-4
quote
The following information was supplied regarding data availability: The data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov). under TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:32953265
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE109211
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE109211
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 4 items
[0] object · 15 fields
id
source:pmid:32953265
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.7717/peerj.9774
sha256
sha256:803ea3be27d2a23b6fdaa688a8b53db832908f4a232ff1f297ffcb6a9d0e4f3f
bytes
47511
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.7717/peerj.9774
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7473097
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE109211
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109211
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE109211
version
null
note
The following information was supplied regarding data availability: The data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov). under TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The following information was supplied regarding data availability: The data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov). under TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211.
access_statement_kind
data_availability_statement
sample_accessions array · 140 items
[0]
GSM2935278
[1]
GSM2935279
[2]
GSM2935280
[3]
GSM2935281
[4]
GSM2935282
[5]
GSM2935283
[6]
GSM2935284
[7]
GSM2935285
[8]
GSM2935286
[9]
GSM2935287
[10]
GSM2935288
[11]
GSM2935289
[12]
GSM2935290
[13]
GSM2935291
[14]
GSM2935292
[15]
GSM2935293
[16]
GSM2935294
[17]
GSM2935295
[18]
GSM2935296
[19]
GSM2935297
[20]
GSM2935298
[21]
GSM2935299
[22]
GSM2935300
[23]
GSM2935301
[24]
GSM2935302
[25]
GSM2935303
[26]
GSM2935304
[27]
GSM2935305
[28]
GSM2935306
[29]
GSM2935307
[30]
GSM2935308
[31]
GSM2935309
[32]
GSM2935310
[33]
GSM2935311
[34]
GSM2935312
[35]
GSM2935313
[36]
GSM2935314
[37]
GSM2935315
[38]
GSM2935316
[39]
GSM2935317
[40]
GSM2935318
[41]
GSM2935319
[42]
GSM2935320
[43]
GSM2935321
[44]
GSM2935322
[45]
GSM2935323
[46]
GSM2935324
[47]
GSM2935325
[48]
GSM2935326
[49]
GSM2935327
[50]
GSM2935328
[51]
GSM2935329
[52]
GSM2935330
[53]
GSM2935331
[54]
GSM2935332
[55]
GSM2935333
[56]
GSM2935334
[57]
GSM2935335
[58]
GSM2935336
[59]
GSM2935337
[60]
GSM2935338
[61]
GSM2935339
[62]
GSM2935340
[63]
GSM2935341
[64]
GSM2935342
[65]
GSM2935343
[66]
GSM2935344
[67]
GSM2935345
[68]
GSM2935346
[69]
GSM2935347
[70]
GSM2935348
[71]
GSM2935349
[72]
GSM2935350
[73]
GSM2935351
[74]
GSM2935352
[75]
GSM2935353
[76]
GSM2935354
[77]
GSM2935355
[78]
GSM2935356
[79]
GSM2935357
[80]
GSM2935358
[81]
GSM2935359
[82]
GSM2935360
[83]
GSM2935361
[84]
GSM2935362
[85]
GSM2935363
[86]
GSM2935364
[87]
GSM2935365
[88]
GSM2935366
[89]
GSM2935367
[90]
GSM2935368
[91]
GSM2935369
[92]
GSM2935370
[93]
GSM2935371
[94]
GSM2935372
[95]
GSM2935373
[96]
GSM2935374
[97]
GSM2935375
[98]
GSM2935376
[99]
GSM2935377
[100]
GSM2935378
[101]
GSM2935379
[102]
GSM2935380
[103]
GSM2935381
[104]
GSM2935382
[105]
GSM2935383
[106]
GSM2935384
[107]
GSM2935385
[108]
GSM2935386
[109]
GSM2935387
[110]
GSM2935388
[111]
GSM2935389
[112]
GSM2935390
[113]
GSM2935391
[114]
GSM2935392
[115]
GSM2935393
[116]
GSM2935394
[117]
GSM2935395
[118]
GSM2935396
[119]
GSM2935397
[120]
GSM2935398
[121]
GSM2935399
[122]
GSM2935400
[123]
GSM2935401
[124]
GSM2935402
[125]
GSM2935403
[126]
GSM2935404
[127]
GSM2935405
[128]
GSM2935406
[129]
GSM2935407
[130]
GSM2935408
[131]
GSM2935409
[132]
GSM2935410
[133]
GSM2935411
[134]
GSM2935412
[135]
GSM2935413
[136]
GSM2935414
[137]
GSM2935415
[138]
GSM2935416
[139]
GSM2935417
sample_count
140
group_sizes
null
group_sizes_basis
null
platform
13938
taxon
Homo sapiens
title
Molecular predictors of prevention of recurrence in hepatocellular carcinoma with sorafenib as adjuvant treatment in the phase 3 STORM trial
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:32953265:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:da9daaacff21a2b0830dff22b7ca776fc7e93613f7c61b60cdb6f00ea129253c
bytes
2827
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#table-1
version
null
note
Association between survival probability and the metabolism-related-gene signature comprising nine genes, in hepatocellular carcinoma patients in the TCGA cohort.
structure object · 5 fields
pmcid
PMC7473097
section_index
12
section_title
Prognostic value of the MRG signature
row_count
25
column_count
10
table object · 8 fields
label
Table 1
caption
Association between survival probability and the metabolism-related-gene signature comprising nine genes, in hepatocellular carcinoma patients in the TCGA cohort.
rows array · 25 items
[0] array · 4 items
[0]
Parameter
[1]
OS cohort
[2]
RFS cohort
[3]
PFS cohort
[1] array · 10 items
[0]
[1]
Volume (High/Low)
[2]
HR (95% CI)
[3]
P-value
[4]
Volume (High/Low)
[5]
HR (95% CI)
[6]
P-value
[7]
Volume (High/Low)
[8]
HR (95% CI)
[9]
P-value
[2] array · 10 items
[0]
Total
[1]
171/172
[2]
2.20 (1.51–3.19)
[3]
<0.001
[4]
150/151
[5]
1.62 (1.16–2.27)
[6]
0.005
[7]
169/168
[8]
1.64 (1.21–2.20)
[9]
0.001
[3] array · 10 items
[0]
Age
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[4] array · 10 items
[0]
≤ 65
[1]
108/108
[2]
1.97 (1.21–3.21)
[3]
0.007
[4]
97/94
[5]
1.62 (1.06–2.47)
[6]
0.027
[7]
108/104
[8]
1.64 (1.13–2.39)
[9]
0.009
[5] array · 10 items
[0]
>65
[1]
63/64
[2]
2.60 (1.42–4.73)
[3]
0.002
[4]
53/57
[5]
1.61 (0.93–2.77)
[6]
0.088
[7]
61/64
[8]
1.62 (0.98–2.67)
[9]
0.061
[6] array · 10 items
[0]
Gender
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[7] array · 10 items
[0]
Male
[1]
118/115
[2]
2.85 (1.73–4.71)
[3]
<0.001
[4]
104/105
[5]
1.77 (1.18–2.66)
[6]
0.006
[7]
116/113
[8]
1.76 (1.21–2.55)
[9]
0.003
[8] array · 10 items
[0]
Female
[1]
53/57
[2]
1.77 (0.96–3.27)
[3]
0.069
[4]
46/46
[5]
1.34 (0.74–2.41)
[6]
0.334
[7]
53/55
[8]
1.42 (0.85–2.38)
[9]
0.181
[9] array · 10 items
[0]
Risk factors
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10] array · 10 items
[0]
HBV + HCV
[1]
67/75
[2]
2.24 (1.08–4.69)
[3]
0.031
[4]
59/65
[5]
1.08 (0.62–1.88)
[6]
0.792
[7]
69/72
[8]
1.32 (0.83–2.10)
[9]
0.242
[11] array · 10 items
[0]
Alcohol intake
[1]
56/55
[2]
1.93 (1.00–3.71)
[3]
0.049
[4]
53/47
[5]
2.15 (1.17–3.95)
[6]
0.014
[7]
57/53
[8]
1.84 (1.08–3.14)
[9]
0.025
[12] array · 10 items
[0]
Degree of fibrosis
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[13] array · 10 items
[0]
No fibrosis
[1]
30/42
[2]
5.89(2.82–12.28)
[3]
<0.001
[4]
25/36
[5]
3.67(1.56–8.66)
[6]
0.003
[7]
29/42
[8]
2.45 (1.34–4.50)
[9]
0.004
[14] array · 10 items
[0]
Fibrosis and cirrhosis
[1]
60/67
[2]
3.55 (1.74–7.27)
[3]
<0.001
[4]
53/58
[5]
2.50 (1.18–5.30)
[6]
0.017
[7]
61/63
[8]
2.55 (1.40–4.64)
[9]
0.002
[15] array · 10 items
[0]
Grade
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[16] array · 10 items
[0]
G1–G2
[1]
83/131
[2]
2.20 (1.38–3.49)
[3]
<0.001
[4]
78/113
[5]
1.78 (1.16–2.74)
[6]
0.008
[7]
81/128
[8]
1.67 (1.13–2.46)
[9]
0.010
[17] array · 10 items
[0]
G3–G4
[1]
86/38
[2]
2.42 (1.12–5.24)
[3]
0.025
[4]
70/35
[5]
1.54 (0.83–2.87)
[6]
0.170
[7]
86/37
[8]
1.68 (0.96–2.95)
[9]
0.071
[18] array · 10 items
[0]
T classification
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[19] array · 10 items
[0]
T1–T2
[1]
120/132
[2]
2.44 (1.45–4.11)
[3]
<0.001
[4]
103/116
[5]
1.81 (1.17–2.77)
[6]
0.007
[7]
120/128
[8]
1.94 (1.34–2.81)
[9]
<0.001
[20] array · 10 items
[0]
T3–T4
[1]
51/37
[2]
1.90 (1.08–3.35)
[3]
0.025
[4]
47/32
[5]
1.21 (0.70–2.10)
[6]
0.488
[7]
49/37
[8]
1.06 (0.63–1.78)
[9]
0.823
[21] array · 10 items
[0]
AJCC stage
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[22] array · 10 items
[0]
Stage I
[1]
63/98
[2]
2.24 (1.13–4.41)
[3]
0.020
[4]
52/86
[5]
1.43 (0.80–2.58)
[6]
0.230
[7]
62/96
[8]
1.53 (0.92–2.53)
[9]
0.099
[23] array · 10 items
[0]
Stage II
[1]
47/30
[2]
2.55 (0.94–6.95)
[3]
0.066
[4]
42/27
[5]
2.05 (0.98–4.31)
[6]
0.057
[7]
47/28
[8]
2.09 (1.07–4.09)
[9]
0.031
[24] array · 10 items
[0]
Stage III and IV
[1]
49/34
[2]
1.86 (1.02–3.39)
[3]
0.043
[4]
45/29
[5]
1.21 (0.68–2.14)
[6]
0.513
[7]
49/34
[8]
1.04 (0.61–1.78)
[9]
0.881
locator
section[12]/table-wrap[1]#table-1
[3] object · 16 fields
id
asset:table:pmid:32953265:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:b33a95345c02cf9897316a1977e808514ea44b132a69690575e8ad48789425e1
bytes
852
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[2]#table-2
version
null
note
Association between overall survival and the metabolism-related-gene signature comprising nine genes, in hepatocellular carcinoma patients in the ICGC cohort.
structure object · 5 fields
pmcid
PMC7473097
section_index
12
section_title
Prognostic value of the MRG signature
row_count
13
column_count
4
table object · 8 fields
label
Table 2
caption
Association between overall survival and the metabolism-related-gene signature comprising nine genes, in hepatocellular carcinoma patients in the ICGC cohort.
rows array · 13 items
[0] array · 2 items
[0]
Parameter
[1]
ICGC cohort
[1] array · 4 items
[0]
[1]
Number (High/Low)
[2]
HR (95% CI)
[3]
P-value
[2] array · 4 items
[0]
Total
[1]
130/100
[2]
5.22 (2.82–9.68)
[3]
<0.001
[3] array · 4 items
[0]
Age
[1]
[2]
[3]
[4] array · 4 items
[0]
≤65
[1]
45/44
[2]
5.58 (1.55–20.11)
[3]
0.009
[5] array · 4 items
[0]
>65
[1]
85/56
[2]
6.47 (1.93–21.72)
[3]
0.002
[6] array · 4 items
[0]
Gender
[1]
[2]
[3]
[7] array · 4 items
[0]
Male
[1]
93/76
[2]
4.51 (1.66–12.25)
[3]
0.003
[8] array · 4 items
[0]
Female
[1]
37/24
[2]
12.41 (1.64–94.14)
[3]
0.015
[9] array · 4 items
[0]
LCSGJ stage
[1]
[2]
[3]
[10] array · 4 items
[0]
Stage I
[1]
22/15
[2]
1.00 (0.82–1.22)
[3]
0.999
[11] array · 4 items
[0]
Stage II
[1]
59/41
[2]
2.68 (0.98–7.36)
[3]
0.056
[12] array · 4 items
[0]
Stage III and IV
[1]
51/45
[2]
17.68 (2.31–135.11)
[3]
0.006
locator
section[12]/table-wrap[2]#table-2
gaps array · 2 items
[0]
asset:data:geo:GSE109211 not downloaded
[1]
asset:data:geo:GSE109211 licence not read
analysis object · 4 fields
state
complete
methods array · 3 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
reordered
quote
Next, the “glmnet” package was used to implement the LASSO Cox regression model. For the discovery cohort (n = 374 patients), fragments per kilobase of exon per million mapped reads (FPKM) data and the corresponding clinical information related to gene expression were downloaded from The Cancer Genome Atlas (TCGA). For the validation cohort (n = 243 patients), the original data and corresponding clinical data related to gene expression were downloaded from the Liver Cancer-RIKEN, Japan (LIRI-JP) project of the International Cancer Genome Consortium (ICGC).
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
[2] object · 10 fields
id
method-3
family
differential_expression
specific
limma_voom
label
Differential expression analysis
dsl_operations array · 3 items
[0]
normalise_counts
[1]
differential_expression_fit
[2]
fdr_bh
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
count_matrix_with_condition
evidence object · 3 fields
score
0.8
band
high
quote
limma
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE109211
resolved_accessions array · 1 item
[0]
GSE109211
statements array · 1 item
[0]
The following information was supplied regarding data availability: The data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov). under TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211.
basis
The paper names GSE109211 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 4 items
[0]
source:pmid:32953265
[1]
data:geo:GSE109211
[2]
asset:table:pmid:32953265:1
[3]
asset:table:pmid:32953265:2
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE109211
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:22:40Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
38704
completion_tokens
1993
cached_tokens
648
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:32953265
type
paper
label
pmid:32953265
[1] object · 3 fields
id
source:pmid:32953265
type
manuscript
label
PMID 32953265 full text
[2] object · 3 fields
id
data:geo:GSE109211
type
dataset
label
GEO GSE109211
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:32953265
type
paper
label
pmid:32953265
[1] object · 3 fields
id
source:pmid:32953265
type
manuscript
label
PMID 32953265 full text
[2] object · 3 fields
id
data:geo:GSE109211
type
dataset
label
GEO GSE109211
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-32953265
type
extraction
used array · 1 item
[0]
source:pmid:32953265
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE109211
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE109211
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:32953265
parent_hash
sha256:dad7e099570d35e6e23f8b87ca7bb33546b4519ef1dd8cd221f5d83a119fef47
fork_of
null
gaps array · 6 items
[0]
asset:data:geo:GSE109211 licence not read
[1]
asset:data:geo:GSE109211 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Next, the “glmnet” package was used to implement the LASSO Cox regression model. For the discovery cohort (n = 374 patients), fragments per kilobase of exon per million mapped reads (FPKM) data and the corresponding clinical information related to gene expression were downloaded from The Cancer Genome Atlas (TCGA). For the validation cohort (n = 243 patients), the original data and corresponding clinical data related to gene expression were downloaded from the Liver Cancer-RIKEN, Japan (LIRI-JP) project of the International Cancer Genome Consortium (ICGC).
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:32953265", "kind": "science-record", "revision": 7, "content_hash": "sha256:50270002525b5e4851090551c10081f269e5a2e5f6e12e26f9a77c90423a46c6", "created_at": "2026-11-01T15:41:10Z", "updated_at": "2026-11-01T22:02:13Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma.", "doi": "10.7717/peerj.9774", "pmid": "32953265", "authors": ["Chaozhi Tang", "Jiakang Ma", "Xiuli Liu", "Zhengchun Liu"], "journal": "PeerJ", "year": 2020, "abstract": "BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common cancer. Since changes in liver metabolism contribute to liver disease development, it is necessary to build a metabolism-related prognostic model for HCC.\nMETHODS: We constructed a metabolism-related-gene (MRG) signature comprising nine genes, which segregated HCC patients into high- and low-risk groups.\nRESULTS: The survival rate (overall survival: OS; relapse-free survival; and progression-free survival) of patients in the low-risk group of The Cancer Genome Atlas (TCGA) cohort was significantly higher than that of patients in the high-risk group. The OS prognostic signature was validated in the International Cancer Genome Consortium independent cohort. The corresponding receiver operating characteristic curves of the model indicated that the signature had good diagnostic efficiency, in terms of improving OS over 1, 3, and 5 years. Hierarchical analysis demonstrated that the MRG signature was significantly associated with better prognosis in male patients, patients aged ≤ 65 years, and patients carrying the wild-type TP53 or CTNNB1 genes. A nomogram was established, and good performance and clinical practicability were confirmed. Additionally, using the GSE109211 dataset from the Gene Expression Omnibus database, we were able to verify that the nine genes in this MRG signature had different responses to sorafenib, suggesting that some of these MRGs may act as therapeutic targets for HCC.\nCONCLUSIONS: We believe that these findings will add value in terms of the diagnosis, treatment, and prognosis of HCC.", "claims": [{"id": "claim-method", "statement": "Next, the “glmnet” package was used to implement the LASSO Cox regression model. For the discovery cohort (n = 374 patients), fragments per kilobase of exon per million mapped reads (FPKM) data and the corresponding clinical information related to gene expression were downloaded from The Cancer Genome Atlas (TCGA). For the validation cohort (n = 243 patients), the original data and corresponding clinical data related to gene expression were downloaded from the Liver Cancer-RIKEN, Japan (LIRI-JP) project of the International Cancer Genome Consortium (ICGC).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32953265", "locator": "sections[4] \"Identification of a prognostic signature based on differential MRG expression\" paragraph 2", "quote": "Next, the “glmnet” package was used to implement the LASSO Cox regression model."}, {"asset": "source:pmid:32953265", "locator": "sections[3] \"Data processing and extraction of differentially expressed MRGs\" paragraph 2", "quote": "For the discovery cohort (n = 374 patients), fragments per kilobase of exon per million mapped reads (FPKM) data and the corresponding clinical information related to gene expression were downloaded from The Cancer Genome Atlas (TCGA)."}, {"asset": "source:pmid:32953265", "locator": "sections[3] \"Data processing and extraction of differentially expressed MRGs\" paragraph 2", "quote": "For the validation cohort (n = 243 patients), the original data and corresponding clinical data related to gene expression were downloaded from the Liver Cancer-RIKEN, Japan (LIRI-JP) project of the International Cancer Genome Consortium (ICGC)."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The following information was supplied regarding data availability:\nThe data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov).\nunder TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32953265", "locator": "sections[31] \"Data Availability Statement\" paragraphs 1-4", "quote": "The following information was supplied regarding data availability:\nThe data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov).\nunder TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:32953265"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE109211"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE109211"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:32953265", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.7717/peerj.9774", "sha256": "sha256:803ea3be27d2a23b6fdaa688a8b53db832908f4a232ff1f297ffcb6a9d0e4f3f", "bytes": 47511, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.7717/peerj.9774", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7473097", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE109211", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109211", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE109211", "version": null, "note": "The following information was supplied regarding data availability:\nThe data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov).\nunder TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The following information was supplied regarding data availability:\nThe data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov).\nunder TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM2935278", "GSM2935279", "GSM2935280", "GSM2935281", "GSM2935282", "GSM2935283", "GSM2935284", "GSM2935285", "GSM2935286", "GSM2935287", "GSM2935288", "GSM2935289", "GSM2935290", "GSM2935291", "GSM2935292", "GSM2935293", "GSM2935294", "GSM2935295", "GSM2935296", "GSM2935297", "GSM2935298", "GSM2935299", "GSM2935300", "GSM2935301", "GSM2935302", "GSM2935303", "GSM2935304", "GSM2935305", "GSM2935306", "GSM2935307", "GSM2935308", "GSM2935309", "GSM2935310", "GSM2935311", "GSM2935312", "GSM2935313", "GSM2935314", "GSM2935315", "GSM2935316", "GSM2935317", "GSM2935318", "GSM2935319", "GSM2935320", "GSM2935321", "GSM2935322", "GSM2935323", "GSM2935324", "GSM2935325", "GSM2935326", "GSM2935327", "GSM2935328", "GSM2935329", "GSM2935330", "GSM2935331", "GSM2935332", "GSM2935333", "GSM2935334", "GSM2935335", "GSM2935336", "GSM2935337", "GSM2935338", "GSM2935339", "GSM2935340", "GSM2935341", "GSM2935342", "GSM2935343", "GSM2935344", "GSM2935345", "GSM2935346", "GSM2935347", "GSM2935348", "GSM2935349", "GSM2935350", "GSM2935351", "GSM2935352", "GSM2935353", "GSM2935354", "GSM2935355", "GSM2935356", "GSM2935357", "GSM2935358", "GSM2935359", "GSM2935360", "GSM2935361", "GSM2935362", "GSM2935363", "GSM2935364", "GSM2935365", "GSM2935366", "GSM2935367", "GSM2935368", "GSM2935369", "GSM2935370", "GSM2935371", "GSM2935372", "GSM2935373", "GSM2935374", "GSM2935375", "GSM2935376", "GSM2935377", "GSM2935378", "GSM2935379", "GSM2935380", "GSM2935381", "GSM2935382", "GSM2935383", "GSM2935384", "GSM2935385", "GSM2935386", "GSM2935387", "GSM2935388", "GSM2935389", "GSM2935390", "GSM2935391", "GSM2935392", "GSM2935393", "GSM2935394", "GSM2935395", "GSM2935396", "GSM2935397", "GSM2935398", "GSM2935399", "GSM2935400", "GSM2935401", "GSM2935402", "GSM2935403", "GSM2935404", "GSM2935405", "GSM2935406", "GSM2935407", "GSM2935408", "GSM2935409", "GSM2935410", "GSM2935411", "GSM2935412", "GSM2935413", "GSM2935414", "GSM2935415", "GSM2935416", "GSM2935417"], "sample_count": 140, "group_sizes": null, "group_sizes_basis": null, "platform": "13938", "taxon": "Homo sapiens", "title": "Molecular predictors of prevention of recurrence in hepatocellular carcinoma with sorafenib as adjuvant treatment in the phase 3 STORM trial", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:32953265:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:da9daaacff21a2b0830dff22b7ca776fc7e93613f7c61b60cdb6f00ea129253c", "bytes": 2827, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#table-1", "version": null, "note": "Association between survival probability and the metabolism-related-gene signature comprising nine genes, in hepatocellular carcinoma patients in the TCGA cohort.", "structure": {"pmcid": "PMC7473097", "section_index": 12, "section_title": "Prognostic value of the MRG signature", "row_count": 25, "column_count": 10}, "table": {"label": "Table 1", "caption": "Association between survival probability and the metabolism-related-gene signature comprising nine genes, in hepatocellular carcinoma patients in the TCGA cohort.", "rows": [["Parameter", "OS cohort", "RFS cohort", "PFS cohort"], ["", "Volume (High/Low)", "HR (95% CI)", "P-value", "Volume (High/Low)", "HR (95% CI)", "P-value", "Volume (High/Low)", "HR (95% CI)", "P-value"], ["Total", "171/172", "2.20 (1.51–3.19)", "<0.001", "150/151", "1.62 (1.16–2.27)", "0.005", "169/168", "1.64 (1.21–2.20)", "0.001"], ["Age", "", "", "", "", "", "", "", "", ""], ["≤ 65", "108/108", "1.97 (1.21–3.21)", "0.007", "97/94", "1.62 (1.06–2.47)", "0.027", "108/104", "1.64 (1.13–2.39)", "0.009"], [">65", "63/64", "2.60 (1.42–4.73)", "0.002", "53/57", "1.61 (0.93–2.77)", "0.088", "61/64", "1.62 (0.98–2.67)", "0.061"], ["Gender", "", "", "", "", "", "", "", "", ""], ["Male", "118/115", "2.85 (1.73–4.71)", "<0.001", "104/105", "1.77 (1.18–2.66)", "0.006", "116/113", "1.76 (1.21–2.55)", "0.003"], ["Female", "53/57", "1.77 (0.96–3.27)", "0.069", "46/46", "1.34 (0.74–2.41)", "0.334", "53/55", "1.42 (0.85–2.38)", "0.181"], ["Risk factors", "", "", "", "", "", "", "", "", ""], ["HBV + HCV", "67/75", "2.24 (1.08–4.69)", "0.031", "59/65", "1.08 (0.62–1.88)", "0.792", "69/72", "1.32 (0.83–2.10)", "0.242"], ["Alcohol intake", "56/55", "1.93 (1.00–3.71)", "0.049", "53/47", "2.15 (1.17–3.95)", "0.014", "57/53", "1.84 (1.08–3.14)", "0.025"], ["Degree of fibrosis", "", "", "", "", "", "", "", "", ""], ["No fibrosis", "30/42", "5.89(2.82–12.28)", "<0.001", "25/36", "3.67(1.56–8.66)", "0.003", "29/42", "2.45 (1.34–4.50)", "0.004"], ["Fibrosis and cirrhosis", "60/67", "3.55 (1.74–7.27)", "<0.001", "53/58", "2.50 (1.18–5.30)", "0.017", "61/63", "2.55 (1.40–4.64)", "0.002"], ["Grade", "", "", "", "", "", "", "", "", ""], ["G1–G2", "83/131", "2.20 (1.38–3.49)", "<0.001", "78/113", "1.78 (1.16–2.74)", "0.008", "81/128", "1.67 (1.13–2.46)", "0.010"], ["G3–G4", "86/38", "2.42 (1.12–5.24)", "0.025", "70/35", "1.54 (0.83–2.87)", "0.170", "86/37", "1.68 (0.96–2.95)", "0.071"], ["T classification", "", "", "", "", "", "", "", "", ""], ["T1–T2", "120/132", "2.44 (1.45–4.11)", "<0.001", "103/116", "1.81 (1.17–2.77)", "0.007", "120/128", "1.94 (1.34–2.81)", "<0.001"], ["T3–T4", "51/37", "1.90 (1.08–3.35)", "0.025", "47/32", "1.21 (0.70–2.10)", "0.488", "49/37", "1.06 (0.63–1.78)", "0.823"], ["AJCC stage", "", "", "", "", "", "", "", "", ""], ["Stage I", "63/98", "2.24 (1.13–4.41)", "0.020", "52/86", "1.43 (0.80–2.58)", "0.230", "62/96", "1.53 (0.92–2.53)", "0.099"], ["Stage II", "47/30", "2.55 (0.94–6.95)", "0.066", "42/27", "2.05 (0.98–4.31)", "0.057", "47/28", "2.09 (1.07–4.09)", "0.031"], ["Stage III and IV", "49/34", "1.86 (1.02–3.39)", "0.043", "45/29", "1.21 (0.68–2.14)", "0.513", "49/34", "1.04 (0.61–1.78)", "0.881"]], "row_count": 25, "column_count": 10, "numeric_cells": 149, "header_rows": 2, "locator": "section[12]/table-wrap[1]#table-1"}}, {"id": "asset:table:pmid:32953265:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:b33a95345c02cf9897316a1977e808514ea44b132a69690575e8ad48789425e1", "bytes": 852, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[2]#table-2", "version": null, "note": "Association between overall survival and the metabolism-related-gene signature comprising nine genes, in hepatocellular carcinoma patients in the ICGC cohort.", "structure": {"pmcid": "PMC7473097", "section_index": 12, "section_title": "Prognostic value of the MRG signature", "row_count": 13, "column_count": 4}, "table": {"label": "Table 2", "caption": "Association between overall survival and the metabolism-related-gene signature comprising nine genes, in hepatocellular carcinoma patients in the ICGC cohort.", "rows": [["Parameter", "ICGC cohort"], ["", "Number (High/Low)", "HR (95% CI)", "P-value"], ["Total", "130/100", "5.22 (2.82–9.68)", "<0.001"], ["Age", "", "", ""], ["≤65", "45/44", "5.58 (1.55–20.11)", "0.009"], [">65", "85/56", "6.47 (1.93–21.72)", "0.002"], ["Gender", "", "", ""], ["Male", "93/76", "4.51 (1.66–12.25)", "0.003"], ["Female", "37/24", "12.41 (1.64–94.14)", "0.015"], ["LCSGJ stage", "", "", ""], ["Stage I", "22/15", "1.00 (0.82–1.22)", "0.999"], ["Stage II", "59/41", "2.68 (0.98–7.36)", "0.056"], ["Stage III and IV", "51/45", "17.68 (2.31–135.11)", "0.006"]], "row_count": 13, "column_count": 4, "numeric_cells": 27, "header_rows": 2, "locator": "section[12]/table-wrap[2]#table-2"}}], "gaps": ["asset:data:geo:GSE109211 not downloaded", "asset:data:geo:GSE109211 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "reordered", "quote": "Next, the “glmnet” package was used to implement the LASSO Cox regression model. For the discovery cohort (n = 374 patients), fragments per kilobase of exon per million mapped reads (FPKM) data and the corresponding clinical information related to gene expression were downloaded from The Cancer Genome Atlas (TCGA). For the validation cohort (n = 243 patients), the original data and corresponding clinical data related to gene expression were downloaded from the Liver Cancer-RIKEN, Japan (LIRI-JP) project of the International Cancer Genome Consortium (ICGC)."}}, {"id": "method-2", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-3", "family": "differential_expression", "specific": "limma_voom", "label": "Differential expression analysis", "dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["count_matrix_with_condition"], "evidence": {"score": 0.8, "band": "high", "quote": "limma"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE109211"], "resolved_accessions": ["GSE109211"], "statements": ["The following information was supplied regarding data availability:\nThe data is available at the Cancer Genome Altas (TCGA, https://cancergenome.nih.gov).\nunder TCGA search term: TCGA-LIHC and from the International cancer genomics consortium (ICGC, https://icgc.org) using ICGC search term: LIRI-JP (https://dcc.icgc.org/releases/current/Projects/LIRI-JP), and NCBI GEO: GSE109211."], "basis": "The paper names GSE109211 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:32953265", "data:geo:GSE109211", "asset:table:pmid:32953265:1", "asset:table:pmid:32953265:2"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE109211"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:22:40Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 38704, "completion_tokens": 1993, "cached_tokens": 648}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:32953265", "type": "paper", "label": "pmid:32953265"}, {"id": "source:pmid:32953265", "type": "manuscript", "label": "PMID 32953265 full text"}, {"id": "data:geo:GSE109211", "type": "dataset", "label": "GEO GSE109211"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:32953265", "type": "paper", "label": "pmid:32953265"}, {"id": "source:pmid:32953265", "type": "manuscript", "label": "PMID 32953265 full text"}, {"id": "data:geo:GSE109211", "type": "dataset", "label": "GEO GSE109211"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-32953265", "type": "extraction", "used": ["source:pmid:32953265"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE109211", "type": "accession_resolution", "used": ["data:geo:GSE109211"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:32953265", "parent_hash": "sha256:dad7e099570d35e6e23f8b87ca7bb33546b4519ef1dd8cd221f5d83a119fef47", "fork_of": null, "generation": 6}, "gaps": ["asset:data:geo:GSE109211 licence not read", "asset:data:geo:GSE109211 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Next, the “glmnet” package was used to implement the LASSO Cox regression model. For the discovery cohort (n = 374 patients), fragments per kilobase of exon per million mapped reads (FPKM) data and the corresponding clinical information related to gene expression were downloaded from The Cancer Genome Atlas (TCGA). For the validation cohort (n = 243 patients), the original data and corresponding clinical data related to gene expression were downloaded from the Liver Cancer-RIKEN, Japan (LIRI-JP) project of the International Cancer Genome Consortium (ICGC)."], "order_basis": "analysis_only", "id": "assay:1"}]}